Your browser doesn't support javascript.
loading
Uterine serous carcinoma: Molecular features, clinical management, and new and future therapies.
Lee, Elizabeth K; Fader, Amanda N; Santin, Alessandro D; Liu, Joyce F.
Afiliação
  • Lee EK; Division of Gynecologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.
  • Fader AN; Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD, United States of America.
  • Santin AD; Department of Obstetrics, Gynecology & Reproductive Sciences, Yale University School of Medicine, New Haven, CT, United States of America.
  • Liu JF; Division of Gynecologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America. Electronic address: joyce_liu@dfci.harvard.edu.
Gynecol Oncol ; 160(1): 322-332, 2021 01.
Article em En | MEDLINE | ID: mdl-33160694
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Uterinas / Cistadenocarcinoma Seroso Tipo de estudo: Clinical_trials Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Uterinas / Cistadenocarcinoma Seroso Tipo de estudo: Clinical_trials Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article